Age38 yrs
Real estate1 parcel · 1,082 m²
Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of APOTHEEK MOPERTINGEN is 0.5% (low). The 2025 annual accounts show equity of €139k and a net result of €139k. The company has been active since 1987 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 1 annual account.
Filing behaviour
From the deposit records, complete market-wideLatest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-06-2026, 46 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 10 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.
Deadline per financial year
| Year closed | Due by | Filed | Variance | Reference |
|---|---|---|---|---|
| 31-12-2025 | 31-07-2026 | 15-06-2026 | 46 d early | 2026-00161549 |
| 31-12-2024 | 31-07-2025 | 26-08-2025 | 26 d late | 2025-00408411 |
| 31-12-2023 | 31-07-2024 | 30-08-2024 | 30 d late | 2024-00436498 |
| 31-12-2022 | 31-07-2023 | 30-08-2023 | 30 d late | 2023-00380827 |
| 31-12-2021 | 31-07-2022 | 29-09-2022 | 60 d late | 2022-20447111 |
| 31-12-2020 | 31-07-2021 | 31-08-2021 | 31 d late | 2021-63500553 |
| 31-12-2019 | 31-07-2020 | 31-08-2020 | 31 d late | 2020-49200108 |
| 31-12-2018 | 31-07-2019 | 28-08-2019 | 28 d late | 2019-54600228 |
| 31-12-2017 | 31-07-2018 | 28-08-2018 | 28 d late | 2018-55800131 |
| 31-12-2016 | 31-07-2017 | 02-08-2017 | 2 d late | 2017-40900310 |
Source: the National Bank's deposit records, as we have ingested them. NOTE: our copy has a gap across June to August 2026, missing roughly 220,000 deposits; for July we hold 15,605 of about 137,000 expected. A year whose deadline falls in that window shows as not confirmed, not as not filed. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.
Trust signals
2 signalsLong-established
Founded in 1987, 38 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.5%
Low
0%0,5%1,5%4%10%≥25%
Long track record
−Higher-failure-rate sector
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Financials
TurnoverNot published (abbreviated schema)
EBIT marginNot published (abbreviated schema)
Net result€139k
Working capital€44k
Annual accounts & ratios
Source: NBB · 2025Annual accounts filed on 15-06-2026 with the NBB · fiscal year 2025 · verkort
| Fiscal year | 2025 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €177k |
| Net profit | €139k |
| Cash flow | €156k |
| Staff costs | - |
| Income taxes | €6k |
| Dividends | €18k |
| Total assets | €858k |
| Equity | €139k |
| Debt | €720k |
| of which ≤ 1y | €530k |
| of which > 1y | €186k |
| Working capital | €44k |
| Employees (FTE) | - |
Ratios (computed)
| 2025 | |
|---|---|
| Current ratio | 1.08 |
| Quick ratio | 0.79 |
| Working capital ratio | 5.1% |
| Solvency | 16.2% |
| Debt / equity | 5.19 |
| Long-term debt ratio | 1.34 |
| Interest coverage | 12.17 |
| Gross margin | - |
| Net margin | - |
| ROA | 16.2% |
| ROE | 100.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Balance-sheet composition 2025
Full annual accounts (25 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €858k |
| Fixed assets | 21/28 | €284k |
| Tangible fixed assets | 22/27 | €284k |
| Financial fixed assets | 28 | €0 |
| Current assets | 29/58 | €575k |
| Stocks & contracts in progress | 3 | €156k |
| Amounts receivable within one year | 40/41 | €393k |
| Cash & bank | 54/58 | €22k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €858k |
| Equity | 10/15 | €139k |
| Contributions / capital | 10/11 | €6k |
| Reserves | 13 | €132k |
| Accumulated profits (losses) | 14 | €0 |
| Amounts payable | 17/49 | €720k |
| Amounts payable after one year | 17 | €186k |
| Amounts payable within one year | 42/48 | €530k |
| Trade debts payable within one year | 44 | €221k |
| Income statement | ||
| Gross operating margin | 9900 | €180k |
| Operating result | 9901 | €160k |
| Financial income | 75 | €70 |
| Financial charges | 65 | €15k |
| Result before taxes | 9903 | €145k |
| Income taxes | 67/77 | €6k |
| Net result for the period | 9904 | €139k |
| Result to be appropriated | 9905 | €139k |
Ratios computed by Checked.
Health barometer
FY 2025 · computed63
/ 100
Healthy
Computed from 4 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Structure & network
Locations & real estate
Registered office
on the map · from the address registerEstablishment units
1 locationAPOTHEEK MOPERTINGEN
since 19882.032.549.084
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area1,082 m²
Buildings1
Building footprint215 m²
Volume (LiDAR)1,244 m³
Tallest building8.1 m · ±2 fl.
Real-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 73055A0522/00X002 | Flanders | 1,082 m² | 1 · 215 m² | 8.1 m · 2 fl. |
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Publications
Lifecycle & Insolvency Signals
No insolvency signals in the Belgian State Gazette
Belgisch Staatsblad · acts
1 act Capital history · 1
09-09-2022
Capital change
All acts · 1
updated 3 years ago
2022
09-09-2022 Transaction in capital or shares
Notary:
Herbert HOUBEN · Genk
Analysis
Financial profile
4 of 5 axes measured68
/ 100
Strong profile, led by profitability.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Health
63
Profitability
100
Solvency
24
Growth
-
Stability
85
Credit advice
verdict per customer and amountSimilar
Similar companies
Same sector and regionBE 1032.855.505 · Bilzen-Hoeselt
BE 0884.869.137 · Bilzen-Hoeselt
BE 0430.114.727 · Bilzen-Hoeselt
BE 0454.490.332 · Bilzen-Hoeselt
BE 0446.212.965 · Bilzen-Hoeselt
We hold no filed accounts for this company, so a size comparison is not possible. These companies share only the sector and the region. We hold annual accounts for 500 of the 5,223 companies in this sector.
Company registry
Company registry (CBE)
Crossroads BankActivities
Detailhandel in farmaceutische producten47730Apothekers52310
Primary activity highlighted.
Names & trade names
| Legal nameNL | APOTHEEK MOPERTINGEN |
Registered office
Maastrichterstraat 414
3740 Bilzen-Hoeselt, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.